Abstract:Background: The human gut microbiota (GM) has been recognized as a significant factor in the development of insomnia, primarily through inflammatory pathways, making it a promising target for therapeutic interventions. Considering the principles of primary prediction, targeted prevention, and personalized treatment medicine (PPPM), identifying specific gut microbiota associated with insomnia and exploring the underlying mechanisms comprehensively are crucial steps towards achieving primary prediction, targeted prevention, and personalized treatment of insomnia. Working hypothesis and methodology: We hypothesized that alterations in the composition of specific GM could induce insomnia through an inflammatory response, which postulates the existence of a GM-inflammation-insomnia pathway. Mendelian randomization (MR) analyses were employed to examine this pathway and explore the mediative effects of inflammation. We utilized genetic proxies representing GM, insomnia, and inflammatory indicators (including 41 circulating cytokines and C-reactive protein (CRP)), specifically identified from European ancestry. The primary method used to identify insomnia-related GM and examine the medicative effect of inflammation was the inverse variance weighted method, supplemented by the MR-Egger and weighted median methods. Our findings have the potential to identify individuals at risk of insomnia through screening for GM imbalances, leading to the development of targeted prevention and personalized treatment strategies for the condition. Results: Nine genera and three circulating cytokines were identified to be associated with insomnia; only the associations of Clostridium (innocuum group) and β-NGF on insomnia remained significant after the FDR test, OR = 1.08 (95% CI = 1.04-1.12, P = 1.45 × 10-4, q = 0.02) and OR = 1.06 (95% CI = 1.02-1.10, P = 1.06 × 10-3, q = 0.04), respectively. CRP was associated with an increased risk of insomnia, OR = 1.05 (95% CI = 1.01-1.10, P = 6.42 × 10-3). CRP mediated the association of Coprococcus 1, Holdemania, and Rikenellaceae (RC9gut group) with insomnia. No heterogeneity or pleiotropy were detected. Conclusions: Our study highlights the role of specific GM alterations in the development of insomnia and provides insights into the mediating effects of inflammation. Targeting these specific GM alterations presents a promising avenue for advancing the transition from reactive medicine to PPPM in managing insomnia, potentially leading to significant clinical benefits. Supplementary information: The online version contains supplementary material available at 10.1007/s13167-023-00345-1.

Identifying insomnia-related chemicals through integrative analysis of genome-wide association studies and chemical-genes interaction information

Integrative Analysis of Genome-Wide Association Study and Brain Region Related Enhancer Maps Identifies Biological Pathways for Insomnia

Identification of key genes and immune infiltration modulated in insomnia by integrated bioinformatics analysis and mendelian randomization study

Integrative analysis of proteome-wide association and transcriptome-wide association study identifies candidate brain proteins associated with insomnia

Identification of potential drug targets for insomnia by Mendelian randomization analysis based on plasma proteomics

Integrative genomics analysis identifies five promising genes implicated in insomnia risk based on multiple omics datasets

Study on the potential mechanism, therapeutic drugs and prescriptions of insomnia based on bioinformatics and molecular docking

Biological and clinical insights from genetics of insomnia symptoms

A genome-wide methylation analysis of Chinese Han patients with chronic insomnia disorder

Identifying 5 Common Psychiatric Disorders Associated Chemicals Through Integrative Analysis of Genome-Wide Association Study and Chemical-Gene Interaction Datasets.

Genome-wide analysis of insomnia in 1,331,010 individuals identifies new risk loci and functional pathways

Investigation of causal effects of blood metabolites on insomnia and circadian rhythm sleep wake disorders

Analysis of the correlation between immune cell characteristics and insomnia: a Mendelian randomization study

Genome-Wide Association Study and Genetic Correlation Scan Provide Insights into Its Genetic Architecture of Sleep Health Score in the UK Biobank Cohort

Polygenic Risk for Insomnia in Adolescents of Diverse Ancestry

The predictive, preventive, and personalized medicine of insomnia: gut microbiota and inflammation

Metabolic Characteristics of Gut Microbiota and Insomnia: Evidence from a Mendelian Randomization Analysis

Evaluating the Effects of Diet-Gut Microbiota Interactions on Sleep Traits Using the UK Biobank Cohort

Insomnia Affects the Levels of Plasma Bilirubin and Protein Metabolism: an Observational Study and GWGEIS in UK Biobank Cohort.

Potential mechanisms of traditional Chinese medicine in treating insomnia: A network pharmacology, GEO validation, and molecular-docking study

Investigating the shared genetic architecture between frailty and insomnia